Cytosorbents's market cap is currently ―. The company's EPS TTM is $-0.634; its P/E ratio is -1.28; Cytosorbents is scheduled to report earnings on April 30, 2024, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 8.81M	$ 9.42M	-	-	$ 6.46M
Gross Profit	$ 5.61M	$ 6.02M	$ -3.99M	$ -3.63M	$ 1.97M
EBIT	$ -9.19M	$ -6.15M	$ -7.34M	$ -1.84M	$ -9.02M
EBITDA	$ -8.73M	$ -5.70M	$ -7.02M	-	$ -8.74M
Net Income Common Stockholders	$ -9.19M	$ -6.15M	$ -7.33M	$ -766.13K	$ -12.20M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 8.36M	$ 13.15M	$ 19.05M	$ 22.14M	$ 22.55M
Total Assets	$ 47.58M	$ 52.44M	$ 57.46M	$ 63.23M	$ 62.27M
Total Debt	$ 18.04M	$ 18.11M	$ 13.17M	$ 18.25M	$ 13.39M
Net Debt	$ 9.68M	$ 4.96M	$ -5.88M	$ -3.89M	$ -9.17M
Total Liabilities	$ 29.06M	$ 28.35M	$ 28.51M	$ 63.23M	$ 23.13M
Stockholders Equity	$ 18.51M	$ 24.09M	$ 28.96M	$ 35.37M	$ 39.14M
Cash Flow	-
Free Cash Flow	$ -5.46M	$ -6.79M	$ -3.79M	$ -5.55M	$ -7.45M
Operating Cash Flow	$ -5.21M	$ -6.93M	$ -3.11M	$ -5.34M	$ -6.73M
Investing Cash Flow	$ -257.71K	$ 140.28K	$ -682.88K	$ -206.08K	$ -716.53K
Financing Cash Flow	$ 648.32K	$ 931.12K	$ 684.28K	$ 5.00M	$ 0.00

Currency in USD

Cytosorbents Earnings and Revenue History

Income Statement >

Cytosorbents Debt to Assets

Balance Sheet >

Cytosorbents Cash Flow

Cash Flow >

Cytosorbents Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing